Pasithea Therapeutics Corp

Analyzing Pasithea Therapeutics Corp (KTTA) After Recent Trading Activity

Daniel Torres

Pasithea Therapeutics Corp’s recent filing unveils that its Director STEINMAN LAWRENCE acquired Company’s shares for reported $100000.0 on Nov 28 ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.